Go Pro

American Healthcare REIT (NYSE:AHR) Releases Earnings Results, Beats Estimates By $0.40 EPS

American Healthcare REIT logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • American Healthcare REIT beat earnings expectations: Quarterly EPS was $0.54, exceeding the $0.14 consensus estimate by $0.40. Revenue rose 24.3% year over year to $445.63 million, though it fell short of the $645.30 million forecast.
  • The company updated its fiscal 2026 EPS guidance to $2.15–$2.19. Shares declined $0.59 to $54.91 after the results, while analysts maintained a “Moderate Buy” consensus with an average price target of $58.83.
  • American Healthcare REIT declared a quarterly dividend of $0.25 per share, equivalent to a $1.00 annualized payout and a 1.8% yield. Insiders sold 29,500 shares worth approximately $1.49 million over the past three months.
  • Five stocks to consider instead of American Healthcare REIT.

American Healthcare REIT (NYSE:AHR - Get Free Report) released its earnings results on Thursday. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.40, Zacks reports. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. The business had revenue of $445.63 million for the quarter, compared to the consensus estimate of $645.30 million. During the same period last year, the firm posted $0.42 earnings per share. The firm's quarterly revenue was up 24.3% compared to the same quarter last year. American Healthcare REIT updated its FY 2026 guidance to 2.150-2.190 EPS.

American Healthcare REIT Stock Performance

Shares of AHR traded down $0.59 during trading hours on Thursday, reaching $54.91. 2,050,158 shares of the company traded hands, compared to its average volume of 2,912,224. The stock's fifty day moving average is $52.03 and its 200 day moving average is $50.66. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.45 and a current ratio of 0.45. American Healthcare REIT has a 1-year low of $39.31 and a 1-year high of $58.70. The stock has a market cap of $10.58 billion, a P/E ratio of 94.67, a price-to-earnings-growth ratio of 1.82 and a beta of 0.76.

American Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.25 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.00 annualized dividend and a dividend yield of 1.8%. American Healthcare REIT's payout ratio is presently 172.41%.

Analysts Set New Price Targets

Several research firms recently issued reports on AHR. Scotiabank reduced their price objective on shares of American Healthcare REIT from $59.00 to $51.00 and set a "sector outperform" rating for the company in a research note on Thursday, June 18th. Royal Bank Of Canada boosted their price target on American Healthcare REIT from $54.00 to $56.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 26th. Citizens Jmp increased their price objective on American Healthcare REIT from $60.00 to $65.00 and gave the company a "market outperform" rating in a report on Monday, July 27th. UBS Group raised their price objective on American Healthcare REIT from $60.00 to $63.00 and gave the company a "buy" rating in a research note on Wednesday, July 8th. Finally, Citigroup reaffirmed an "outperform" rating on shares of American Healthcare REIT in a research report on Monday, July 27th. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $58.83.

Check Out Our Latest Analysis on American Healthcare REIT

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, EVP Mark E. Foster sold 2,500 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $48.58, for a total transaction of $121,450.00. Following the completion of the transaction, the executive vice president directly owned 52,995 shares in the company, valued at $2,574,497.10. This represents a 4.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Brian Peay sold 25,000 shares of the firm's stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $50.70, for a total transaction of $1,267,500.00. Following the sale, the chief financial officer directly owned 152,700 shares of the company's stock, valued at approximately $7,741,890. The trade was a 14.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 29,500 shares of company stock worth $1,485,590. 0.75% of the stock is currently owned by insiders.

Institutional Trading of American Healthcare REIT

Several hedge funds have recently modified their holdings of AHR. Garton & Associates Financial Advisors LLC bought a new stake in shares of American Healthcare REIT during the fourth quarter worth $26,000. Kemnay Advisory Services Inc. acquired a new stake in shares of American Healthcare REIT during the 4th quarter worth approximately $29,000. Darwin Wealth Management LLC acquired a new position in American Healthcare REIT in the second quarter valued at approximately $31,000. Los Angeles Capital Management LLC acquired a new stake in American Healthcare REIT during the 4th quarter worth $34,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of American Healthcare REIT during the 4th quarter valued at $35,000. 16.68% of the stock is owned by institutional investors.

About American Healthcare REIT

(Get Free Report)

American Healthcare REIT, Inc NYSE: AHR was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company's portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.

Further Reading

Earnings History for American Healthcare REIT (NYSE:AHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines